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 Abstract 20 
 Campylobacter jejuni (C. jejuni) is gastroenteritis inducible food-born pathogen. 21 
Invasion and adhesion process are essential for leading gastroenteritis in C. 22 
jejuni infection process. As against bacterial strategy for efficacy invasion and 23 
adhesion, mucosal layer play a key role in defense systems, which modulated by 24 
several ion channels and transporters mediated water flux on the intestine. 25 
Cystic fibrosis transmembrane conductance regulator (CFTR) play the main role 26 
in waterfulux in intestine, and it closely related with bacterial clearance. We 27 
previously reported that C. jejuni infection suppresses CFTR channel activity in 28 
intestinal epithelial cells, however the mechanism and importance of this 29 
suppression is unclear. This study seeks to elucidate the role of CFTR in C. 30 
jejuni-infection. Using HEK293 cells that stably express wild type and mutated 31 
CFTR, we found that CFTR attenuated C. jejuni invasion, it was not involved 32 
bacterial adhesion or intracellular survival but associated with 33 
microtubule-dependent cellular transport. Moreover we revealed that CFTR 34 
attenuated function of microtubule motor protein but not microtubule stability, 35 
which causes inhibition of C. jejuni-invasion. Meanwhile, the CFTR mutant 36 
 4 
G551D-CFTR, which has defects in channel activity, suppressed C. 37 
jejuni-invasion, whereasΔF508-CFTR, which has defects in maturation, did not 38 
suppress, suggesting that CFTR suppression of C. jejuni-invasion is related to 39 
CFTR maturation but not channel activity. 40 
 Taken together, mature CFTR inhibited C. jejuni invasion by regulating 41 
microtubule-mediated pathways. We suggest that CFTR plays a critical role in 42 
cellular defenses against C. jejuni-invasion, and CFTR suppression may be an 43 





 Campylobacter jejuni (C. jejuni) is a spiral-shaped Gram-negative bacterium 48 
that is commonly found in the gut microflora of birds or domestic animals used 49 
for food. C. jejuni is the most common cause of bacterial food-borne illness 50 
worldwide and causes gastrointestinal symptoms such as diarrhea, fever, 51 
abdominal cramping, and gastroenteritis. Despite its frequency, the virulence 52 
factors that contribute to C. jejuni-induced gastroenteritis remain largely 53 
unknown. Genomic studies revealed that C. jejuni strains lack type III secretion 54 
systems that are essential for the virulence of many other Gram-negative enteric 55 
pathogens (1). Thus, C. jejuni pathogenesis likely involves multifactorial 56 
virulence processes, including motility, adherence, invasion, and intracellular 57 
survival (2,3). Indeed, a study that examined mutant C. jejuni strains that were 58 
defective in adhesion or invasion found that cultured cells infected with these 59 
strains had decreased secretion of the pro-inflammatory cytokine IL-8 (4,5), 60 
which suggests that adhesion and invasion are the main pathogenic processes 61 
in C. jejuni infection (6,7,8,9).  62 
 6 
 In the human gut, the mucosal layer represents the first defense against 63 
bacterial adhesion and invasion (10). The binding of intestinal bacteria to host 64 
epithelial cells is assumed to play a fundamental role in intestinal bacterial 65 
colonization and disease progression (11). A previous study reported that mutant 66 
mice with defective mucosal function had a high colonization rate in C. 67 
jejuni-inoculation models (12). The mucosal layer consists of mucins, which are 68 
high molecular mass oligomeric glycoproteins. This layer is also critical for 69 
maintaining gut homeostasis by regulating water flux through the activity of 70 
several ion transporters and ion channels in the intestine (13). Among these ion 71 
channels, the cystic fibrosis transmembrane conductance regulator (CFTR), a 72 
cAMP-activated chloride channel, is one of the most important factors that 73 
governs water movement. CFTR is expressed in several tissues such as those 74 
in the lung, pancreas, liver, intestine, sweat ducts, and reproductive system 75 
(14,15). In the intestinal tract, CFTR is associated with intestinal tract hydration 76 
and clearance of intestinal contents, including bacteria (16).   77 
 CFTR activation can disrupt the water balance in the gut to lead to diarrhea that 78 
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is associated with intestinal infections caused by pathogens such as Escherichia 79 
coli (17) and Vibrio cholera (18) as well as other infectious bacteria (19). 80 
However, we previously reported that C. jejuni infection suppressed 81 
CFTR-mediated Cl- secretion in intestinal cells (20), which is in opposition to 82 
clinical C. jejuni symptoms such as diarrhea. Thus, the relationship between 83 
CFTR suppression and C. jejuni infection is unclear.  84 
 In order to investigate the relationship between CFTR suppression and C. jejuni 85 
infection, we referred to respiratory infections that occur in the presence of 86 
CFTR mutations that are also associated with cystic fibrosis (CF) (21). CF 87 
patients frequently experience respiratory bacterial infection caused by 88 
Pseudomonas aeruginosa (P. aeruginosa) or Burkholderia cenocepacia (22). 89 
CFTR dysfunction disrupts CFTR-mediated water flux that in turn affects 90 
mucosal layer function and attenuates bacterial clearance such that bacteria 91 
accumulate in the respiratory tract. Epithelial cells in CF patients have increased 92 
cell surface expression of Toll-like receptors (TLR5 and TLR2), contribution of 93 
TLR2 has been questioned, and enhanced inflammatory responses (23). 94 
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Moreover, P. aeruginosa is reported to suppress CFTR channel activity by 95 
secreting proteins that promote severe inflammation (24,25). These reports 96 
indicated that CFTR plays a defensive role against respiratory infection, and 97 
dysfunctional CFTR may promote conditions that increase the likelihood of 98 
bacterial infection.    99 
 In this study, we studied the role of CFTR in C. jejuni infection. Our data 100 
showed that CFTR expression decreased C. jejuni invasion. In particular, CFTR 101 
expression inhibited microtubule-mediated transport processes during C. jejuni 102 
invasion, suggesting that CFTR might be a protective factor against C. jejuni 103 
infection.  104 
  105 
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Material and Methods 106 
Bacterial strains and culture conditions. The Campylobacter jejuni strains 107 
NCTC11168 (ATCC 700819) and 81-176 (ATCC BAA2151) were purchased 108 
from American Type Culture Collection (ATCC). Bacteria were grown in Muller 109 
Hinton (MH) broth (DIFCO 275730) at 37 ℃ under microaerobic conditions (5% 110 
O2, 10% CO2 and 85% N2) for 36 hours. Bacteria were then collected by 111 
centrifugation of the media at 12,000 rpm for 3 minutes, concentrated, and 112 
grown on selective supplemental media containing Campylobacter charcoal 113 
differential agar (CCDA:OXOID) for 36 hours. Single colonies were picked and 114 
grown in MH broth for 48 hours, after which the media was centrifuged at 12,000 115 
rpm 3 minutes, diluted into 15% glycerol (Wako) and stored at -80 ℃.  116 
 For the experiments, samples from frozen bacterial strains were grown in MH 117 
broth for 48 hours under microaerobic conditions. After centrifugation at 12,000 118 
rpm for 3 min, the supernatant was removed and the pellet was diluted into fresh 119 
MH broth and cultured for 36 hours. Bacteria were collected by centrifuging the 120 
media at 3,000 rpm for 15 minutes, and the supernatant was removed. The 121 
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bacterial cells were washed with phosphate buffered saline (PBS(-): 137 mM 122 
NaCl, 8.1 mM anhydrous Na2HPO4, 2.68 mM KCl, 1.47 mM KH2PO4), 123 
centrifuged and resuspended in PBS(-). Finally, bacterial cell numbers were 124 
adjusted to an optical density of 600 nm for OD600=1.0.  125 
Reagents and antibodies. Forskolin and VX-809 were purchased from 126 
Calbiochem and AdooQ Bioscience, respectively. Methyl-β-cyclodextrin (mβ-cd), 127 
chlorpromazine hydrochloride, paclitaxel and nocodazole were purchased from 128 
Sigma-Aldrich. The following antibodies were diluted in 3% skim milk and used 129 
for western blotting: CFTR (1:1,000, Millipore), α-tubulin (1:2,000, Wako), and 130 
β-actin (1:2,000, Santa Cruz). 131 
Cell culture. Human embryonic kidney cells (HEK293) were cultured for 3-4 132 
days in Dulbecco’s modified eagle’s medium (DMEM) high glucose (Sigma) 133 
supplemented with 10% FBS (Thermo-Fisher), and 50 μg/ml gentamicin (Sigma) 134 
at 37℃ and 5% CO2. The human intestinal epithelial cell line T-84 was cultured 135 
for 7 days in Ham’s F-12 media (DMEM/F-12, 1:1, Sigma) supplemented with 136 
10% FBS (Thermo), and 50 μg/ml gentamicin (Sigma) at 37 ℃ and 5% CO2. 137 
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The culture medium was changed every 2 days.  138 
Stable transfection of HEK293 cells. HEK293 cells were seeded at a density 139 
of 5×105 cells/35 mm dish and incubated for 24 hours. Media was changed to 140 
DMEM high glucose without FBS and 1 ml Gentamicin High Glucose free. HG 141 
free (200 μl) was mixed with 1 μg/well pcDNA-wt-CFTR vector and 4 μg/well 142 
Lipofectamine 2000 (Invitrogen) for 15 minutes before incubating at 37℃ for 3 143 
hours. The cells were then incubated overnight at 37℃ in DMEM high glucose 144 
containing 20% FBS and 50 μg/ml gentamicin (1.2 ml total). The supernatant 145 
was removed, and the cells were washed with 1 ml 0.02% EDTA/ PBS (-) and 146 
then 1 ml 0.02%EDTA/PBS (-) was added and the cells were incubated at 37℃ 147 
for 5 minutes. The cells were collected by centrifugation at 800 rpm for 3 minutes, 148 
and incubated with DMEM high glucose supplemented with 1 mg/ml G418, 10% 149 
FBS, and gentamicin for 10 days to produce cells that stably express CFTR. 150 
Colonies were picked with paper filter, incubated in a 24-well plate for 2 days 151 
before the filter was removed and the cells were grown to confluence. CFTR 152 
protein expression was assessed by western blotting and cells with high 153 
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expression levels were selected. Cells stably expressing mutated CFTR were 154 
produced using the same method. 155 
Western blotting. Cultured cells were washed with PBS (-), diluted into RIPA 156 
buffer (pH 7.4, 50 mM Tris-HCl, 150 mM NaCl, 1 mM EDTA, 1% sodium 157 
deoxycholate, 0.1% SDS, 1% Triton-X) + 10% protease inhibitor mixture 158 
(Nacalai Tesque), centrifuged at 15,000 rpm for 10 min at 4℃ , and the 159 
supernatant was collected. Protein levels were determined using a BCA Protein 160 
assay kit (Thermo). Samples were added to 5× sample buffer (pH 6.8, 250 mM 161 
Tris-HCl, 5% SDS, 25% 2-mercaptoethanol, 50% glycerol, BPB) and separated 162 
on a SDS-polyacrylamide gel (7.5% or 10%). Proteins were transferred to 163 
Immobilon-P Transfer Membranes (Millipore) that were blocked with Tris 164 
Buffered Saline with Tween-20 (TBS-T: pH 7.6, 20 mM Tris, 150 mM NaCl, 165 
0.02% Polyoxyethylene (20) sorbitan monolaurate) containing 3% skim milk for 1 166 
hour at RT and incubated overnight at 4 ℃ with primary antibodies in TBS-T 167 
containing 3% skim milk. After washing with TBS-T for 30 minutes, membranes 168 
were exposed to horseradish peroxidase-conjugated secondary antibodies 169 
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(1:2,000, anti mouse Ig HRP, Biosource) for 2 hours at RT. Membranes were 170 
then washed with TBS-T for 30 minutes and detected with ECL (GE Healthcare). 171 
Hyperfilm ECL (GE Healthcare) and imaging with a Fuji medical film processor 172 
FPM 100 was used to detect CFTR expression. β-actin protein was detected 173 
used medical X-ray film or LASS-2000. 174 
Efflux assay. Cells were seeded at a density of 5×105 cells/well in a 6-well plate 175 
and incubated for 4 days. The supernatants were removed, exchanged for 176 
HEPES buffer (10 mM HEPES, 145 mM NaCl, 10 mM glucose, 5 mM KCl, 1 mM 177 
MgCl2, 1 mM CaCl2) containing 125I- (2 μCi/ml) and incubated at 37 ℃ for 1 178 
hour. The media was removed and the cells were washed twice with isotope-free 179 
HEPES buffer before exchanging either for HEPES buffer or HEPES buffer 180 
containing 10 μM forskolin. After 5 minutes, supernatants were recovered for 181 
sample detection. Cells were incubated 0.1 M NaOH at 37 ℃ for 1 hour and  182 
samples were collected to detect intracellular 125I- using a gamma-counter. The 183 
total amount of 125I- in the supernatant and cells was calculated as:  % Efflux = 184 
(125I- secretion amount /(125I- cellular amount + 125I- secretion amount))×100    185 
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Transient transfection with shRNA. HEK-wt-CFTR or HEK-G551D-CFTR cells 186 
were seeded at a density of 1×106 cells/well in 6-well plates. Cells were then 187 
washed and the media was replaced with HG free before transfection with 1 μg 188 
pLKO-CFTR vector or pLKO.1-puro Non-Target shRNA Control vector using 189 
Lipofectamine 2000 reagent (Invitrogen) for 3 hours. DMEM-HG(+) containing 190 
20 % FBS and 50 μg/ml gentamicin was then added to the cells. 191 
 T84 cells were cultured for 7 days and the cells were harvested with 0.05% 192 
trypsin-EDTA and diluted in HEPES buffer. pLKO-CFTR vector or pLKO.1-puro 193 
Non-Target shRNA Control vector (2.5-5ug) were mixed with T-84 cells 194 
suspension cultures (4×105 / 24well) for 20 minutes. Cells were electroporated 195 
with 50 voltage-20 ms for 3 times. After electroporation, cells were suspended 196 
culture medium for 48 hours.    197 
Invasion and adhesion and degradation assay. For an invasion assay, 198 
HEK293 cells and HEK-wt-CFTR cells were seeded at a density of 4×105 199 
cells/well in 6-well plates and incubated at 37 ℃ for 4 days. The supernatants 200 
were removed and replaced with HG-free media before the cells were infected 201 
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with C. jejuni at a multiplicity of infection (MOI) of 50 for 6 hours at 37 ℃ in 5% 202 
CO2. After infection, the supernatant was replaced with DMEM-HG(+) containing 203 
100 μg/ml gentamicin for 2 hours. The supernatant was removed and the cells 204 
were washed with PBS (-) and lysed with PBS containing 1% Triton-X. The 205 
lysates were plated on MH agar plates and incubated for 48 hours under 206 
microaerobic conditions. HEK-ΔF508-CFTR cells were treated with VX-809 or 207 
DMSO at 27 ℃ for 24 hours before infection.  208 
 For adhesion assays, HEK293 cells and HEK-wt-CFTR cells were seeded at a 209 
density of 1×106 cells/well in 60 mm well plates. After infection, the supernatants 210 
were removed and the cells were washed with PBS (-) three times before lysing 211 
at 37℃ for 5 minutes in PBS (-) containing 0.01% Triton-X. Cell lysates were 212 
plated on MH agar plates and incubated for 48 hours under microaerobic 213 
conditions. 214 
 In degradation assays, HEK293 cells and HEK-wt-CFTR cells were seeded at a 215 
density of 4×105 cells/well in 6-well plates. After infection, the supernatants were 216 
removed and replaced with DMEM-HG(+) containing 100 μg/ml gentamicin for 2, 217 
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4, 6, or 8 hours. The cells were then lysed with PBS (-) containing 1% Triton-X, 218 
plated on MH agar plates, and incubated for 48 hours under microaerobic 219 
conditions. All intracellular bacterial number normalized with 1×107 cell. 220 
Separation of soluble and insoluble tubulin. HEK293 cells and 221 
HEK-wt-CFTR cells were seeded at a densitiy of 4×105 cells/well in 6-well plates. 222 
The supernatant was removed and the cells were washed with PBS (-) before 223 
adding microtubule buffer (0.1 M PIPES pH 7.6, 2 M glycerol, 5 mM MgCl2, 2 224 
mM EGTA) containing 0.1% Triton-X, 1 mM PMSF, 5 μg/ml aprotinin and 225 
leupeptin and incubating for 10 min RT. Cells were collected and centrifuged for 226 
10 min at 300 g at room temperature. The resulting supernatant represented the 227 
soluble fraction. Meanwhile, pellets containing the insoluble fraction were 228 
washed again with microtubule buffer and treated with lysis buffer (25 mM 229 
Na2HPO4 pH 7.2, 400 mM NaCl, 0.5% SDS), and centrifuged for 10 min at 230 
20,000 g. Protein concentrations were measured with a BCA protein assay kit 231 
and equal amounts of protein were separated by SDS-PAGE. Anti-α-tubulin and 232 
anti-β-actin antibodies were used for western blotting. 233 
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RNA isolation and RT-PCR 234 
Total RNA was extracted from T-84 cells using RNeasy Mini Kit (QIAGEN 235 
74104) according to the manufacture’s instruction. Reverse transcription were 236 
preformed with 1 μg of total RNA using the PrimeScript RT-Reagent Kit 237 
(TaKaRa RR037A). Quantitative real-time reverse-transcription PCR was 238 
performed in the LightCycler Real Time PCR System (Roche Applied Science) 239 
with SYBER Premix ExTaq (TaKaRa RR820). 18S ribosomal RNA 240 
housekeeping gene (as internal control) and CFTR primers are as follow: 241 
forward: 5’-AAACGGCTACCACATCCAAG-3’ and reverse: 242 
5’-GGCCTCGAAAGAGTCCTGTA-3’, forward: 243 
5’GCAGTTGATGTGCTTGGCTAG-3’ and reverse: 244 
GAATCGTACTGCCGCACTTTG-3’, respectively. Fold change was calculated 245 
relatively to 18S.    246 
Statistical Analysis 247 
All data were performed statistical analysis by using Student’s t-test for paired 248 
data. Data were done 3 independent experiments. All tests were one-tailed; 249 
*p<0.05; ** p<0.01, NS.: not significant. 250 
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Results 251 
Exogenous CFTR expressed cells were useful for the analyzing of CFTR 252 
effect on C. jejuni infection 253 
 In our previous study, CFTR channel activity was suppressed by C. jejuni 254 
infection (Figure 1A) in T-84 cells, endogenous CFTR expressing cells. To 255 
examine whether C. jejuni infection affect exogenous CFTR, we established 256 
CFTR-expressing HEK293 (HEK-wt-CFTR cells). CFTR expression and channel 257 
activity were confirmed by western blot (supplementary Figure 1A) and efflux 258 
assay (supplementary Figure 1B), respectively. Interestingly, in contrast to the 259 
T-84 cells, CFTR ion channel activity was not suppressed by C. jejuni infection in 260 
HEK-wt-CFTR cells (Figure 1B). Together, these results suggest that C. jejuni 261 
infection did not directly affect CFTR function. Thus, we used HEK-wt-CFTR 262 
cells, in this study, to assess the CFTR contribution on the C. jejuni-infection.  263 
 264 
Numbers of intracellular C. jejuni bacteria were decreased by CFTR 265 
expression 266 
 Adhesion and invasion processes are thought to be essential for C. jejuni 267 
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virulence and infection (26) and decreased amounts of CFTR expression 268 
induced by C. jejuni may provide increased opportunities for bacterial adhesion 269 
or invasion. To test whether CFTR expression levels were related to C. jejuni 270 
invasion, we investigated the numbers of intracellular bacteria in 271 
CFTR-expressing cells infected with C. jejuni. Relative to HEK293 cells, 272 
HEK-wt-CFTR cells infected by C. jejuni for 6 hours showed reduced amounts of 273 
C. jejuni invasion (Figure 1C). Next, HEK-wt-CFTR cells were transfected with a 274 
CFTR knockdown vector expressing shRNA specific for CFTR, pLKO-CFTR 275 
(shCFTR). Cells transfected with pLKO.1-puro Non-Target shRNA control vector 276 
(shControl) were used as control and knockdown efficiency was confirmed by 277 
western blotting (Figure 1D). CFTR knockdown increased intracellular bacterial 278 
cellular numbers were assessed with a gentamicin protection assay (Figure 1E). 279 
The results indicated that C. jejuni invasion was prevented by CFTR expression. 280 
Another C. jejuni strain, 81-176, which was isolated from a patient during an 281 
outbreak of Campylobacter enteritis (27) gave the same results as the NCTC 282 
11168 strain (Supplementary Figure 2A and B). Therefore CFTR attenuated 283 
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invasion by another C. jejuni strain infection.  284 
 285 
CFTR attenuated microtubule-mediated C. jejuni invasion processes 286 
 Since the number of intracellular bacterial cells in host cells can be influenced 287 
at several steps, including adhesion, invasion, and survival, we next assessed 288 
the relationship between CFTR and C. jejuni in the context of these processes. 289 
In terms of C. jejuni cell numbers, adhesion and survival, there were no 290 
differences between control cells and CFTR-expressing cells (Figure 2A and C). 291 
In contrast, C. jejuni invasion was decreased by CFTR expression during the 292 
early stage of infection (Figure 2B). Thus, we focused on C. jejuni invasion 293 
pathways, which have two main parts: the endocytosis-like uptake pathway (26) 294 
and the microtubule-dependent cellular transport pathway (28). Endocytosis-like 295 
uptake pathways include those involving lipid rafts or clathrin-mediated 296 
processes (29). Lipid raft domains are rich in cholesterol that promotes bacterial 297 
adhesion and produces bacteria-containing vacuoles for cellular uptake (30). 298 
Meanwhile, the scaffold protein clathrin binds to adaptor proteins to generate 299 
 21 
clathrin-coated vesicles and promote endocytosis (31). Mβ-cd can affect lipid raft 300 
components such as cholesterol to inhibit lipid raft-mediated endocytosis (32). 301 
Chlorpromazine prevents clathrin formation at the cell membrane to decrease 302 
clathrin-mediated endocytosis activity (33). Here, treatment of cells with either 303 
mβ-cd or chlorpromazine dramatically decreased the extent of C. jejuni invasion 304 
in control cells. However, CFTR-mediated suppression of C. jejuni invasion was 305 
sustained (Figure 3A and B). These data indicated that the effect of CFTR on C. 306 
jejuni invasion was not related to the activity of endocytosis pathways.  307 
Microtubules are dynamic structures that undergo polymerization and 308 
depolymerization of tubulin to regulate both cell skeleton integrity and cellular 309 
transport (34). After entry into host cells, C. jejuni invasion proceeds along 310 
microtubules that act as intracellular tracks (28). Here, treatment with the 311 
microtubule polymerization inhibitors nocodazole or colchicine (35,36) 312 
suppressed C. jejuni invasion, but there was no difference in the number of 313 
intracellular bacterial in control cells or cells CFTR-expressing cells (Figure 3C). 314 
These data implied that CFTR negatively affected intracellular transport of C. 315 
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jejuni via the microtubule track, which in turn inhibited invasion.   316 
  317 
CFTR expression affect microtubule motor protein 318 
 Microtubule polymerization promotes bacterial uptake and vacuole motility (37). 319 
For C. jejuni, microtubules provide a means for invasion (28). To investigate the 320 
participation of CFTR in microtubule-mediated C. jejuni invasion, we focused 321 
microtubule tract and motor protein.  322 
 First, we investigated CFTR effect on microtubule transport tract. C. jejuni 323 
infection did not change the amount of polymerized microtubules 324 
(supplementary Figure 3A and B). The amount of polymerized microtubules was 325 
estimated by western blot in CFTR-expressing cells (Figure 4A). But there were 326 
no differences between HEK293 and HEK-wt-CFTR cells. And we confirmed 327 
microtubules stability in CFTR-expressing cells by using the microtubule 328 
depolymerization inhibitor, paclitaxel. Microtubule polymerization was increased 329 
by paclitaxel treatment in CFTR-expressing cells (Figure 4B). Also, according th 330 
the microtubule polymerization, the number of intracellular bacteria was 331 
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increased by paclitaxel treatment in HEK293 cells (Figure 4C). However, in 332 
HEK-wt-CFTR cells, the intracellular bacterial number did not increase 333 
significantly similar to HEK293 cells. These data indicated that CFTR did not 334 
affect microtubule tract stability in microtubule-mediated transport. 335 
 Next, we checked that CFTR effect on microtubule motor protein, dynein. In the 336 
previous study reported tht dynein inhibitor Na3O4 decreased C. jejuni invasion 337 
via microtubule-mediated transport (38). Thus we used dynein inhibitor, Na3VO4, 338 
on CFTR expressing cells, to stop the delivery in microtubule tract. According to 339 
the Na3VO4 content, intracellular bacteria were decreased, and the differences 340 
of bacterial number between HEK-wt-CFTR shControl and shCFTR cells were 341 
abolished by Na3VO4 treatment (Figure 4D). Another strains, C. jejuni 81-176, 342 
also result in similar to 11168 (supplementary Figure 4). 343 
 These results suggest that CFTR suppressed microtubule motor protein, which 344 
functions interfere with microtubule mediated C. jejuni invasion. 345 
 346 
CFTR maturation is essential to inhibit C. jejuni invasion 347 
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Cellular surface localization and appropriate folding are necessary for CFTR 348 
channel activity (14,15). To examine how CFTR inhibited C. jejuni invasion, we 349 
established cell lines that stably expressed two different CFTR mutants. The 350 
G551D-CFTR mutant has a substitution of aspartic acid for glycine at amino acid 351 
position 551. This mutant has appropriate folding trafficking to the cell surface 352 
membrane, but does not have channel activity (39). Meanwhile, the 353 
ΔF508-CFTR mutant has a single deletion of a phenylalanine residue at position 354 
508. This mutant does not have appropriate glycosylation, folding, or trafficking 355 
to the cell surface membrane (40). The expression of the mutant CFTR proteins 356 
was confirmed by western blot (supplementary Figure 5A). Band C, indicative of 357 
the mature complex-glycosylated form of CFTR, was detected for both wt-CFTR 358 
and G551D-CFTR. Bands A and B indicate the non-glycosylated form and 359 
immature core-glycosylated form, respectively, of CFTR (41). Band A and B 360 
were both detected for cells expressing ΔF508-CFTR. The ion channel activity 361 
as measured by efflux assay showed that active ion channels were detected 362 
only for wt-CFTR cells (supplementary Figure 5B). Cells expressing the G551D 363 
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CFTR mutant, HEK-G551D-CFTR, had inhibition of C. jejuni invasion that was 364 
similar to that of wt-CFTR cells (Figure 5A). G551D-CFTR knockdown also had 365 
increases in intracellular bacterial cell numbers (Figure 5B and C). These results 366 
indicated that suppression of C. jejuni invasion by CFTR expression was not 367 
associated with CFTR ion channel activity. In contrast, expression of 368 
ΔF508-CFTR did not suppress C. jejuni invasion (Figure 5A). A previous study 369 
showed that defects in folding and trafficking of ΔF508-CFTR could be rescued 370 
by treatment of cells with pharmacological folding correctors such as VX-809 at 371 
low temperature conditions (27 ℃) (42). Here we showed that treatment of cells 372 
with VX-809 at low temperatures facilitated CFTR maturation and increased the 373 
amount of band C, which indicates mature complex-glycosylated CFTR (Figure 374 
5D). During CFTR maturation, C. jejuni invasion was suppressed by expressing 375 
mature ΔF508-CFTR in the presence of VX-809 (Figure 5E). These results 376 
suggest that CFTR expression, especially expression of mature and cell 377 
surface-localized CFTR, was important for C. jejuni invasion. 378 
 379 
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Endogenous CFTR attenuated C. jejuni invasion 380 
 Next we confirmed CFTR-mediated suppression of C. jejuni invasion in 381 
endogenously CFTR expressed T-84 cells. The shControl and shCFTR vector, 382 
were transfected into T-84 cells by electroporation to assesse whether 383 
endogenous CFTR also inhibits C. jejuni invasion. We checked CFTR 384 
knockdown efficiency by western blotting (Figure 6A). Similar to the 385 
HEK-wt-CFTR experiment, intracellular bacterial number was increased by 386 
endogenous CFTR knockdown in 3 hours C. jejuni infection (Figure 6B). Finally, 387 
we checked endogenous CFTR express ion level in C. jejuni infected T-84 cells. 388 
In order to examine the mechanism how C. jejuni suppresses CFTR channel 389 
activity in T-84 cells (Figure 1A). And we revealed that C. jejuni attenuated CFTR 390 
gene expression and protein level in long term, 12 hours, infection (Figure 6C 391 
and D). Taken together, these results suggest that, in intestinal cells, C. jejuni 392 
suppressed CFTR to effectively into host cells.   393 
  394 
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Discussion 395 
 In this study, we investigated the role of CFTR in C. jejuni infection. We found 396 
that overexpression of CFTR specifically inhibited invasion of C. jejuni (Figures 2 397 
and 3) and that this inhibition appeared to depend on microtubules for transport 398 
of C. jejuni vacuoles needed for bacterial invasion (Figures 4 and 5). C. jejuni 399 
invasion was not suppressed in cells expressing an immature mutant CFTR that 400 
is defective in glycosylation and trafficking, whereas cells expressing a CFTR 401 
mutant that lacked ion channel activity had C. jejuni invasion that was similar to 402 
that seen for HEK cells expressing wild type CFTR (Figure 6). Thus, we 403 
conclude that CFTR glycosylation and localization to the cell surface might affect 404 
bacterial interactions with cellular microtubules to suppress bacterial invasion.  405 
 The specific functions of intestinal epithelial cells, such as mucus production or 406 
cellular polarization, might affect invasion processes of C. jejuni. Because we 407 
focused on the relationship between CFTR and C. jejuni infection, we 408 
overexpressed CFTR in HEK293 cells, a fibroblast line. 409 
 CFTR at the cell surface has several functional domains that have specific 410 
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structures, including two membrane-spanning domains, two nucleotide-binding 411 
domains, and a regulatory region (14,15). The carboxyl terminal domain of 412 
CFTR includes a PDZ domain that interacts with the cellular cytoskeleton by 413 
binding scaffolding proteins such as NHERF1, N-WASP, EZRIN, and F-actin. 414 
Localization of CFTR on the cell surface helps regulate clathrin and 415 
N-WASP-mediated endocytosis pathways as well as Rab11 and 416 
Rme-1-mediated recycling pathways. The ΔF508-CFTR mutant is thought to 417 
have impaired interactions with NHERF1 and attenuated stabilization at the cell 418 
surface (43). We considered that expression of wild type CFTR would result in 419 
stable cell surface CFTR and increased interactions with scaffolding proteins 420 
that in turn inhibit C. jejuni invasion. However, future studies should include 421 
quantification of the amount of cell surface CFTR, which was examined only at a 422 
qualitative level in this study.  423 
 During C. jejuni-invasion, microtubule tracts were associated with 424 
CFTR-dependent inhibition of C. jejuni invasion (Figures. 4 and 5). Motor 425 
proteins, such as members of the dynein and kinesin families, slide along 426 
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microtubules and are important for microtubule-mediated cellular transport (44). 427 
Dynein and kinesin transports cargo toward the perinuclear region and from the 428 
perinuclear region to the cell surface, respectively. CFTR trafficking is 429 
maintained by microtubule-dependent transport involving dynein. Thus, CFTR 430 
expression could regulate microtubule motor protein function, which might affect 431 
delivery of C. jejuni vacuoles along microtubule tracts from the cell surface. 432 
Further studies will also be needed to characterize the relationship between 433 
CFTR and motor protein function. 434 
 Recently, other intestinal infection bacteria, including enteropathogenic 435 
Escherichia coli (EPEC) and Salmonella typhimurium (S. typhimurium), were 436 
reported to suppress CFTR ion channel activity (45,46). Moreover, in the 437 
respiratory tract P. aeruginosa was shown to invade host cells via a 438 
microtubule-dependent pathway that is regulated by CFTR (47). These findings 439 
suggest that regulation of microtubule function by CFTR might be essential for 440 
protection against invasive bacterial infection in a variety of tissues.  441 
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Figure Legends 600 
Figure 1. Changing of intracellular C. jejuni numbers in the presence of 601 
CFTR expression Cl- efflux rates were estimated by 12 hours C. jejuni infected 602 
cells in (A) T-84 cells and (B) HEK-wt-CFTR cells. After the stimulation, 125I- 603 
was incorporated into cells for 6 minutes and the levels were assessed using a 604 
gamma counter. (C) HEK293 cells and HEK-wt-CFTR cells were infected by C. 605 
jejuni for 6 hours. The number of intracellular bacteria was estimated with a 606 
gentamicin protection assay. (D) HEK-wt-CFTR cells were transfected with 607 
pLKO-CFTR vector or pLKO.1-puro Non-Target shRNA control vector and the 608 
protein expression of CFTR was detected by western blot. (E) HEK-wt-CFTR 609 
shControl cells and HEK-wt-CFTR shCFTR cells were infected by C. jejuni for 6 610 
hours and intracellular bacteria numbers were estimated with a gentamicin 611 
protection assay. All data are means ± SD of 3 independent experiment. 612 
Statistical significance: **, p<0.01. NS.,No Significance. n=3-6. 613 
 614 
Figure 2. CFTR affects C. jejuni invasion during the early phase of infection 615 
time, but does not affect bacterial adhesion and cellular survival. 616 
 42 
HEK-wt-CFTR cells were transfected with shControl or shCFTR vectors. The 617 
cells were then infected by C. jejuni and (A) bacterial adhesion, (B)  invasion 618 
and (C) intracellular survival were assessed after 0, 1, 3 hours. All data are 619 
means ±SD of 3 independent experiment. Statistical significance: **, p<0.01. 620 
NS.,No Significance. n=3-6. 621 
 622 
Figure 3. CFTR affected microtubule tracks in C. jejuni invasion. HEK293 623 
cells and HEK-wt-CFTR cells were treated with (A) methyl-β-cyclodextrin; mβ-cd 624 
(7.5 mM), (B) chlorpromazine (47 μM), (C) nocodazole (33 μM), or colchicine (10 625 
μM) for 1 hour, and infected by C. jejuni for 3 hours. In all experiments, the 626 
number of intracellular bacteria was estimated using a gentamicin protection 627 
assay. All data are means ± SD of 3 independent experiment. Statistical 628 
significance: **, p<0.01., *, p<0.05 NS. , No Significance. n=3-6. 629 
 630 
Figure 4. CFTR expression attenuated affect microtubule motor protein  in 631 
C. jejuni invasion. (A) The polymerized tubulin content in HEK293 and 632 
 43 
HEK-wt-CFTR cells were assessed by western blotting, treatment with paclitaxel 633 
(5, 10 μM) or DMSO for 1 hour.  (B) The changing of microtubule 634 
polymerization were quantified by measurement of polymerized α-tubulin and 635 
normalized with respect to β-actin that was used as a loading control. (C) 636 
HEK293 and HEK-wt-CFTR cells were treated with paclitaxel (5 or 10 μM) or 637 
DMSO for 1 hour prior to C. jejuni infection. And Intracellular bacterial numbers 638 
were assessed by gentamicin protection assay. (D) HEK-wt-CFTR cells  639 
shControl and shCFTR cells were treated by Na3VO4 (1 or 2 mM) for 1 hour prior 640 
to C. jejuni infection. Intracellular bacterial numbers were assessed with 641 
gentamicin protection assay. . All data are means ±SD of 3 independent 642 
experiment. Statistical significance: **, p<0.01., *, p<0.05 NS. , No Significance. 643 
n=3-6. 644 
 645 
Figure 5. Immature CFTR did not inhibit C. jejuni invasion. (A) HEK293, 646 
HEK-wt-CFTR, HEK-G551D-CFTR, or HEK-ΔF508-CFTR cells were infected 647 
with C. jejuni for 0, 1, and 3 hours. Numbers of intracellular bacteria were 648 
 44 
estimated using a gentamicin protection assay. (B) HEK-G551D cells were 649 
transiently transfected with shControl or shCFTR, and CFTR levels were 650 
detected by western blot. (C) HEK-G551D shControl and shCFTR cells were 651 
infected with C. jejuni for 6 hours. Numbers of intracellular bacteria were 652 
estimated with a gentamicin protection assay. (D) HEK-ΔF508-CFTR cells were 653 
treated with VX-809 (40 μM) or DMSO at 27 °C for 24 hr. CFTR expression was 654 
detected by western blot. Bands A, B, and C indicate non-glycosylated, 655 
immature core-glycosylated, and mature complex-glycosylated CFTR, 656 
respectively. (E) HEK-ΔF508 and HEK-wt-CFTR cells were treated with VX-809 657 
or DMSO at 27 ℃ for 24 hours and infected by C. jejuni for 3 hours. The 658 
number of intracellular bacteria was estimated using a gentamicin protection 659 
assay.  All data are means ±SD of 3 independent experiment. Statistical 660 
significance: **, p<0.01., *, p<0.05., NS. , No Significance., n=3-6. 661 
 662 
Figure 6. Endogenous CFTR inhibited C. jejuni invasion in intestinel cells 663 
 (A) CFTR knockdown level in, T-84 shControl and shCFTR cells, were detected 664 
 45 
by western blotting. (B) The T-84, induced shControl and shCFTR plasmid, cells 665 
were infected by C. jejuni 3 hours infection and estimated intracellular bacterial 666 
number by gentamicin protection assay. During the 12 hours C. jejuni-infection, 667 
CFTR (C) mRNA and (B) protein expression level were estimated in T-84 cells. 668 
All data are means ±SD of 3 independent experiment. Statistical significance: **, 669 
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supplementary Figure 1. HEK-wt-CFTR cells stably and functionally 
express wt-CFTR. (A) HEK293 cells transfected with pcDNA-wt-CFTR 
vector stably expressed CFTR (HEK-wt-CFTR) as detected by western 
blot. (B) HEK293 cell and HEK-wt-CFTR cells were treated with forskolin
or DMSO and CFTR channel activity was measured by assessing 
intracellular levels of 125I- isotope incorporated into cells for 5 minutes 
prior to measurement with a gamma counter system. All data are 
means ±SD of 3 independent experiment. Statistical significance: **, 
p<0.01
FIG S2.
































































supplementary Figure 2. CFTR expression inhibited invasion by other 
jejuni strains (NCTC 11168 and 81-176). (A) HEK293 cells were infected 
by NCTC 11168 or 81-176 C. jejuni strains for 0, 3, 6, 9, or 12 hours. The 
number of intracellular bacteria were estimated using a gentamicin 
protection assay. (B) HEK293, HEK-wt-CFTR, HEK-wt-CFTR shControl and 
HEK-wt-CFTR shCFTR cells were infected by C. jejuni (81-176) for 6 
hours. The numbers of intracellular bacteria were estimated with a 
gentamicin protection assay. All data are means ±SD of 3 independent 
































supplementary Figure 3. C. jejuni infection did not affect tubulin 
polymerization. HEK293 cells and HEK-wt-CFTR cells were infected 
with C. jejuni for 3 hours. The level of polymerized tubulin was assessed 
with a western blot using an α-tubulin antibody and normalized relative 

























supplementary Figure 4. CFTR expression inhibited microtubule-
dependent invasion with other jejuni strains (81-176). (A) HEK293 cells 
and HEK-wt- CFTR cells were treated with nocodazole, colchicine, and 
Na3VO4 before 1 hour infection. The number of intracellular bacteria 
were estimated using a gentamicin protection assay. All data are means 
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FIG S5.
supplementary Figure 5. Stable expression of mutant CFTR in 
transfected HEK293 cells. (A) HEK293 cells were transfected with 
pCDNA-G551D-CFTR and pCDNA-Δ-F508-CFTR. CFTR expression was 
detected by western blot and (B) CFTR channel activity was measured 
with an efflux assay.
